🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "targeted steps to tackle cost of living challenges" in next month's Budget.

In comments to media outlets, she noted that reducing price rises is a collective task of both the government and the central bank.

The UK's inflation rate is forecast to be the highest among the Group of Seven developed nations this year and next.

Possible Utility Bill Measures

It is understood the government could intervene to bring down utility costs, for example by cutting the present 5% rate of VAT charged on energy supplies.

An additional possibility is to reduce some of the government charges presently included in bills.

Budgetary Constraints and Analyst Predictions

The administration will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much space there is for these measures.

The consensus from the majority of analysts is that Reeves will have to declare tax rises or spending cuts in order to adhere to her self-imposed borrowing rules.

Previously on the same day, analysis suggested there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the lower end of projections.

"It is a collective responsibility between the central bank and the government to continue tackling some of the causes of inflation," the Chancellor told reporters in the US capital, at the conferences of the IMF and World Bank.

Tax Commitments and International Issues

While a great deal of the attention has been on probable tax increases, the chancellor said the most recent figures from the OBR had not changed her vow to campaign commitments not to increase tax levels on income tax, sales tax or social security contributions.

She attributed an "unpredictable global environment" with growing geopolitical and trade tensions for the Budget tax moves, probably to be focused on those "with the broadest shoulders."

Global Trade Disputes

Commenting on concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security invariably take priority."

Last week's announcement by China to strengthen export controls on critical minerals and other materials that are crucial for advanced tech production led US President the US President to threaten an further 100% import tax on goods from the Asian country, raising the prospect of an all-out commercial conflict between the two global powers.

The American finance chief called China's move "commercial pressure" and "a global supply chain control attempt."

Questioned on accepting the US offer to participate in its dispute with the Asian nation, Reeves said she was "very concerned" by Chinese measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "damaging for the global economy and creates additional obstacles."

"It is my opinion there are areas where we should challenge China, but there are also valuable opportunities to sell into China's economy, including banking sector and other sectors of the economy. We've got to get that balance appropriate."

The chancellor also confirmed she was working with other major economies "on our own critical minerals approach, so that we are less reliant."

Health Service Drug Costs and Investment

The Chancellor also recognized that the price the NHS spends on medicines could go up as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

A number of the biggest global drug companies have said lately that they are either pausing or abandoning operations in the United Kingdom, with some blaming the insufficient payments they are getting.

Last month, the Science Minister said the price the NHS pays for medicines would have to increase to prevent firms and drug research funding departing from the United Kingdom.

The Chancellor stated to the BBC: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been offered in the UK in the way that they are in other continental states."

"The objective is to ensure that individuals getting treatment from the NHS are able to obtain the best life-saving drugs in the globe. And so we are looking at all of that, and... looking to attract increased funding into Britain."